- Home
- NIM vs RCEL Comparison
NIM vs RCEL Comparison
Compare NIM & RCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NIM
- RCEL
- Stock Information
- Founded
- NIM 1992
- RCEL N/A
- Country
- NIM United States
- RCEL United States
- Employees
- NIM N/A
- RCEL N/A
- Industry
- NIM Trusts Except Educational Religious and Charitable
- RCEL Medical/Dental Instruments
- Sector
- NIM Finance
- RCEL Health Care
- Exchange
- NIM Nasdaq
- RCEL Nasdaq
- Market Cap
- NIM 116.0M
- RCEL 107.8M
- IPO Year
- NIM N/A
- RCEL N/A
- Fundamental
- Price
- NIM $9.35
- RCEL $3.75
- Analyst Decision
- NIM
- RCEL Buy
- Analyst Count
- NIM 0
- RCEL 5
- Target Price
- NIM N/A
- RCEL $11.80
- AVG Volume (30 Days)
- NIM 35.4K
- RCEL 263.1K
- Earning Date
- NIM 01-01-0001
- RCEL 11-06-2025
- Dividend Yield
- NIM 3.46%
- RCEL N/A
- EPS Growth
- NIM N/A
- RCEL N/A
- EPS
- NIM N/A
- RCEL N/A
- Revenue
- NIM N/A
- RCEL $72,401,000.00
- Revenue This Year
- NIM N/A
- RCEL $19.96
- Revenue Next Year
- NIM N/A
- RCEL $33.43
- P/E Ratio
- NIM N/A
- RCEL N/A
- Revenue Growth
- NIM N/A
- RCEL 20.59
- 52 Week Low
- NIM $8.28
- RCEL $3.35
- 52 Week High
- NIM $9.74
- RCEL $14.16
- Technical
- Relative Strength Index (RSI)
- NIM 51.87
- RCEL 38.44
- Support Level
- NIM $9.19
- RCEL $3.88
- Resistance Level
- NIM $9.42
- RCEL $3.91
- Average True Range (ATR)
- NIM 0.10
- RCEL 0.24
- MACD
- NIM 0.00
- RCEL -0.02
- Stochastic Oscillator
- NIM 52.00
- RCEL 41.90
About NIM Nuveen Select Maturities Municipal Fund
Nuveen Select Maturities Municipal Fund is a diversified closed-end management investment company. Its primary investment objective is to provide current income exempt from regular federal income tax, consistent with the preservation of capital. Its secondary investment objective is to enhance portfolio value relative to the municipal bond market through investments in tax-exempt municipal obligations that are underrated or undervalued, or that represent municipal market sectors that are undervalued.
About RCEL Avita Medical Inc.
Avita is a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult and paediatric patients in the US and an expanded indication for soft-tissue reconstruction. It is currently in rollout across the approximately 136 US burn centers. Despite having product approval in Australia, Europe, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region. However, it is expected to launch in Japan via distribution partner Cosmotec in second-half fiscal 2022. Avita is domiciled, and has its primary listing, in the US.